High clinical and morphologic response using Y-90-DOTA-octreotate sequenced with Lu-177-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours Journal Articles Refereed uri icon

Overview

Published in

  • European Journal of Nuclear Medicine and Molecular Imaging

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1007/s00259-016-3527-x

Additional Document Info

Parent Title

  • EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Volume

  • 44

Issue

  • 3

Publisher

  • Springer Verlag